Further HF concern in rosiglitazone use

The use of rosiglitazone in older diabetic patients can increase the risk of heart failure by 60 per cent, according to US research.

The findings add to concerns raised in May, when researchers showed rosiglitazone use was associated with a 63 per cent increased risk of death from a cardiovascular cause.

Data was analysed on 159,026 patients, aged 66 and over, who were treated for type-2 diabetes. Four-year follow up revealed that 7.9 per cent of patients had a hospital visit for heart failure and 19 per cent died of a cardiovascular cause.

Compared with other combination oral hypoglycaemic agent treatments, such as metformin, patients taking rosiglitazone had a 60 per cent increased risk of congestive heart failure, a 40 per cent increased risk of heart attack and a 29 per cent increased risk of cardiovascular death.

Dr Allastair Benbow, European medical director for GSK, the company that manufactures rosiglitazone (Avandia), said that there was a wealth of data to back up its use.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Practices are deluged with work, yet many people still think they are ‘closed’. The...

Start date for COVID-19 booster campaign unclear, vaccines minister admits

Start date for COVID-19 booster campaign unclear, vaccines minister admits

A UK COVID-19 booster campaign could start from September - but could also remain...

BMA demands 'systemic change' after LMC report exposes racism in primary care

BMA demands 'systemic change' after LMC report exposes racism in primary care

Most black, Asian and minority ethnic primary care staff have experienced racism...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...